Groin

New York's Top Hernia and Core Surgeon Mark Zoland M.D. F.A.C.S. Receives Castle Connolly's 2024 Top Doctor® Award

Retrieved on: 
星期二, 一月 23, 2024

NEW YORK, Jan. 23, 2024 /PRNewswire-PRWeb/ -- Dr. Mark Zoland, a highly esteemed medical professional, has been honored with the prestigious title of 2024 Castle Connolly Top Doctor. This recognition places him among the top 7% of all doctors nationally, highlighting his exceptional skills and dedication to providing outstanding healthcare. Dr. Zoland's nomination by his peers adds an extra layer of significance to this achievement. It is a testament to his exceptional reputation within the medical community, as well as his unwavering commitment to his patients' well-being. For over three decades, Castle Connolly has been the foremost authority in identifying and honoring Top Doctors who consistently deliver exceptional care. As the most trusted source for patients seeking best-in-class healthcare providers, Castle Connolly takes great pride in recognizing medical professionals like Dr. Zoland, who exemplify a longstanding commitment to their patients. Dr. Zoland's impressive educational background includes a bachelor's degree from Columbia University and a medicine degree from Cornell University Medical College in 1993. Since 2001, he has been board-certified and a Fellow of the American College of Surgeons, showcasing his expertise and dedication to his field. Dr. Mark Zoland specializes in surgery for many conditions, including complex hernias and groin injuries. He leads an elite medical team at Core Surgical in New York City. Dr. Zoland offers unparalleled knowledge and experience, providing the highest level of care in areas such as hernia repair, groin pain, pelvic pain, sports-related groin/pelvic injuries and non-surgical treatment recommendations.

Key Points: 
  • NEW YORK, Jan. 23, 2024 /PRNewswire-PRWeb/ -- Dr. Mark Zoland , a highly esteemed medical professional, has been honored with the prestigious title of 2024 Castle Connolly Top Doctor.
  • For over three decades, Castle Connolly has been the foremost authority in identifying and honoring Top Doctors who consistently deliver exceptional care.
  • More about Dr. Mark Zoland and Core Surgical:
    Dr. Mark Zoland and Dr. Joseph Iraci lead the team of pelvic and groin medical professionals at their advanced surgical center in New York City.
  • To schedule a consultation with Dr. Mark Zoland or for more information about Core Surgical, please visit http://www.coresurgicalmd.com or call (212) 628-8771
    View original content to download multimedia: https://www.prweb.com/releases/new-yorks-top-hernia-and-core-surgeon-mar...

SPR® Therapeutics Announces Extensive Set of Abstracts to be Shared at North American Neuromodulation Society (NANS) Annual Meeting 2024

Retrieved on: 
星期二, 一月 16, 2024

CLEVELAND, Jan. 16, 2024 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc. will be featured prominently at the North American Neuromodulation Society (NANS) Annual Meeting January 18-21 in Las Vegas.

Key Points: 
  • CLEVELAND, Jan. 16, 2024 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc. will be featured prominently at the North American Neuromodulation Society (NANS) Annual Meeting January 18-21 in Las Vegas.
  • A total of 11 abstracts highlighting applications of the SPRINT® PNS System will be featured at the meeting including four posters never before presented to the industry.
  • The presentation reviews treatment costs for patients in two cohorts who started treatment either with SPRINT PNS or with a conventional brief PNS trial.
  • The poster reviews health economics and outcomes research to explore the economic implications of the use of SPRINT PNS in chronic low back pain.

Scabies: UK facing unusually large outbreaks – and treatment shortages appear mostly to blame

Retrieved on: 
星期五, 一月 5, 2024

Outbreaks happen regularly – with an estimated 450 million cases occurring globally each year.

Key Points: 
  • Outbreaks happen regularly – with an estimated 450 million cases occurring globally each year.
  • But since the start of winter, outbreaks in the UK have been higher than normal.
  • While there a probably a few factors that can explain this spike, treatment shortages appear to be at the heart of it.
  • The skin rash is also more severe, with a crust over the surface of the infected area.
  • Itching may take up to a month to completely subside after treatment.

Outbreak causes

  • This means mites spread more easily in places where people come into close contact with each other for extended periods of time – such as schools, universities and prisons.
  • Residential care and nursing homes are particularly high-risk settings for scabies outbreaks, with vulnerable populations and staff members alike at risk of infection.
  • Another factor in the outbreak could be stigma against having scabies, with many people claiming the disease is caused by being unclean or a lack of bathing.
  • In reality, there’s no good evidence about a lack of washing being a risk factor.
  • While some evidence suggests that scabies incidence is higher in the winter, in reality outbreaks can happen at any time of the year.
  • Since September 2023, there’s been a shortage of both permethrin and malathion in the UK due to supply issues.

Preventing infection

  • If anyone has symptoms that might be scabies or another skin infection, such as itching and a rash or skin wounds, these should be reported to a doctor or healthcare provider as early as possible.
  • This is especially important if they have potentially been in close contact with a known case.
  • Scabies outbreaks can be brought under control – but diagnosis and treatment as early as possible is required for that to happen.


Michael Head has previously received funding from the Bill & Melinda Gates Foundation and the UK Department for International Development, and currently receives funding from Research England and the UK Medical Research Foundation.

Clínica Camila Samara offers personalized treatments for the body and well-being in Brazil

Retrieved on: 
星期日, 十二月 24, 2023

Her goal is to offer her clients the best aesthetic treatments, making them feel good about themselves and consequently raising their self-esteem.

Key Points: 
  • Her goal is to offer her clients the best aesthetic treatments, making them feel good about themselves and consequently raising their self-esteem.
  • Camila Samara offers services with cutting-edge technologies to provide customers with unique and personalized experiences.
  • Personalized service Camila Samara works from Monday to Saturday and on one day of the week she offers personalized service at home.
  • This way, I set aside one day a week to serve them “in the comfort of their homes, with more convenience,” said Camila Samara.

Aurora Spine Corporation Announces Newly Published Paper on First 6-month Clinical Evaluation of its ZIP™ Fusion Implant

Retrieved on: 
星期一, 十二月 4, 2023

This 6-month interim analysis at 42% enrollment of patients was conducted to determine prolonged safety and efficacy of the ZIP interspinous fusion device.

Key Points: 
  • This 6-month interim analysis at 42% enrollment of patients was conducted to determine prolonged safety and efficacy of the ZIP interspinous fusion device.
  • Dr. Sebastian Koga, a neurosurgeon from Covington, LA emphasized, “Our study demonstrates that the ZIP device provides a stable platform for posterior fusion.
  • I am happy to contribute objective clinical evidence to this area of spine surgery.
  • A previously published retrospective study has also demonstrated the ZIP device’s safety and effectiveness in the hands of interventional pain physicians.

Rapid Medical's TIGERTRIEVER™ Delivers First-Pass Success in Challenging Ischemic Stroke Patients with ICAD

Retrieved on: 
星期四, 十一月 16, 2023

Rapid Medical™, a leading developer of advanced neurovascular devices, announces new data demonstrating excellent first-pass treatment success with the TIGERTRIEVER™ device in complex ischemic stroke patients with underlying intracranial atherosclerotic disease (ICAD).

Key Points: 
  • Rapid Medical™, a leading developer of advanced neurovascular devices, announces new data demonstrating excellent first-pass treatment success with the TIGERTRIEVER™ device in complex ischemic stroke patients with underlying intracranial atherosclerotic disease (ICAD).
  • “Patients with ICAD experiencing a stroke are very challenging to treat and often need rescue therapy such as stenting,” states Dr. Edgar Samaniego , Endovascular Neurologist at the University of Iowa and lead author.
  • “We achieved very high treatment success and lasting results with TIGERTRIEVER alone that we haven’t seen with other devices.
  • Moreover, TIGERTRIEVER in ICAD rivals the results only thought possible in non-ICAD patients.

Increasing Incidence of Kidney Stone Disease Drives Growth in Stone Management Disposables Market, with Calcium Oxalate Stones Dominating - ResearchAndMarkets.com

Retrieved on: 
星期三, 十一月 8, 2023

The model discusses in detail the impact of COVID-19 on Stone Management Disposables market for the year 2020 and beyond.

Key Points: 
  • The model discusses in detail the impact of COVID-19 on Stone Management Disposables market for the year 2020 and beyond.
  • Nephrolithiasis, or kidney stone disease, is a condition in which individuals form stones in the kidney or urinary tract.
  • Kidney stones can be classified based on their chemical composition: calcium oxalate, calcium phosphate, uric acid, cysteine, struvite.
  • Calcium oxalate stones are the most commonly formed stones and account for approximately 82% of stone cases.

Dermavant Presents Positive Results from Phase 4 Open-Label Trial of VTAMA® (tapinarof) Cream, 1% for the Treatment of Intertriginous Plaque Psoriasis in Adults at 43rd Annual Fall Clinical Dermatology Conference

Retrieved on: 
星期五, 十月 20, 2023

Intertriginous plaque psoriasis, also known as inverse psoriasis, affects approximately 20%–30% of individuals who have plaque psoriasis.

Key Points: 
  • Intertriginous plaque psoriasis, also known as inverse psoriasis, affects approximately 20%–30% of individuals who have plaque psoriasis.
  • The treatment for plaque psoriasis in intertriginous areas is specifically challenging, because these sensitive areas are more prone to potential adverse effects from existing steroidal-topical treatments.
  • DMVT-505-4001 (NCT05680740) was a Phase 4, open-label multi-center study that evaluated the efficacy and safety of VTAMA (tapinarof) cream, 1% in adults with intertriginous plaque psoriasis (iPsO).
  • Indication: VTAMA® (tapinarof) cream, 1% is an aryl hydrocarbon receptor agonist indicated for the topical treatment of plaque psoriasis in adults.

Merit Medical Launches Expanded Maestro® Microcatheter Line

Retrieved on: 
星期二, 十月 10, 2023

SOUTH JORDAN, Utah, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the expansion of its Maestro Microcatheter product line to now include a new longer length for radial embolization procedures.

Key Points: 
  • SOUTH JORDAN, Utah, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the expansion of its Maestro Microcatheter product line to now include a new longer length for radial embolization procedures.
  • The new 165-cm Maestro length will be available in 2.1F, 2.4F, 2.8F, and 2.9F catheter diameters to support a broad range of embolization procedures.
  • “Merit Maestro’s longer length is ideal for radial access,” said Mary Costantino, MD, interventional radiologist at Advanced Vascular Centers in Oregon, and a paid consultant of Merit.
  • Radial artery access is a minimally invasive approach to diagnosing and treating a wide range of medical conditions.

Burke Civil Rights Litigation Team Secures Defense Verdict for the City of Los Angeles

Retrieved on: 
星期五, 十月 6, 2023

A Burke, Williams & Sorensen, LLP Litigation team representing the City of Los Angeles and LAPD officer Brandon Purece secured a high profile defense jury verdict in a Los Angeles Superior Court civil rights action (Bradley Steyn v. City of Los Angeles, et al., 20STCV34657).

Key Points: 
  • A Burke, Williams & Sorensen, LLP Litigation team representing the City of Los Angeles and LAPD officer Brandon Purece secured a high profile defense jury verdict in a Los Angeles Superior Court civil rights action (Bradley Steyn v. City of Los Angeles, et al., 20STCV34657).
  • Burke partner Brian S. Ginter led the Burke defense team, which included partner Charles E. Slyngstad , associate attorney Kyle Anne Piasecki , and paralegal Phil Paley.
  • Ginter opined, “A jury accurately and fairly determined that Officer Purece used reasonable force and did not violate Mr. Steyn’s rights.
  • Burke, Williams & Sorensen, LLP is a California limited liability law partnership with 161 member attorneys.